The prevalence of obesity and related disorders has vastly increased throughout the 22 world and prevention of such circumstances thus represents a major challenge. Here, 23 we show that protein-bound β-glucan (PBG), one representative of Coriolus versicolor 24 polysaccharopeptides which are broadly used as immune boosters and clinically 25 implicated in treatment of cancers and chronic hepatitis, could be a potent anti-obesity 26 agent. PBG could reduce obesity and metabolic inflammation in mice fed with a 27 high-fat diet (HFD). Gut microbiota analysis revealed that PBG markedly increased the 28 abundance of Akkermansia muciniphila although it didn't rescue HFD-induced change 29 in the Firmicutes to Bacteroidetes ratio. It appeared that PBG altered host physiology 30 and created an intestinal microenvironment favorable for A. muciniphila colonization.
Introduction generated and each fecal sample produced an average of 54,074±4,309 effective reads. 114 Samples with a low number of effective reads (<1622) were not observed. High-quality 115 reads were clustered into Operational Taxonomic Units (OTUs). 116 Principal coordinates analysis (PCoA) of unweighted UniFrac distances of fecal 117 microbiota was plotted, based on OTU abundances (Fig. 3a) . The PCoA scores clearly 118 display a distinct clustering of microbiota composition for each treatment group. 119 Simvastatin treatment induces a mild shift of gut microbiota in HFD-fed mice, while 120 intake of PBG leads to a more pronounced change in microbiota composition. The 121 UPGMA (unweighted pair-group method with arithmetic means) tree also indicates 122 there is a remarkable separation between the microbiota from most mice for each 123 treatment (Fig. 3b ). 124 Analysis of bacterial relative abundance confirmed prior reports that gut microbial 125 communities of mice are dominated by bacteria from the Firmicutes and Bacteroidetes 126 phyla ( Fig. 3b ) and that HFD feeding increases the proportion of Firmicutes versus 127 Bacteroidetes (20). It appear that either PBG or simvastatin treatment doesn't rescue 128 HFD-induced change in the Firmicutes to Bacteroidetes ratio (Fig. 3c) . The most increased and 23 decreased), while PGB daily at a dose of 400 mg/kg altered 140 136 OTUs (29 increased and 111 decreased). Detailed analysis of the Top 100 OTUs 137 indicated that the following 4 genera, Akkermansia, Bacteroides, Bacterium, and 138 Ruminiclostridium_10 were profoundly increased in PBG-treated HFD-fed mice. The 139 most striking one was Akkermansia, which was identified as the sole genus in the 140 phylm Verrucomicrobia. PBG increased the percentage of Akkermansia from 5.67 ± 141 1.5% to 22.1 ± 2.3% (p < 0.0001) at a daily dose of 400 mg/kg. It remains to be determined whether the interaction between PBG and the gut 145 microbiota, Akkermansia is direct or indirect (i.e., mediated through promoting 146 bacterial growth or altering host physiology). The in vitro analysis indicated that PBG 147 couldn't directly promote the growth of A. muciniphila in the pure culture ( Fig.4a ). To 148 see whether PBG affected the growth of A. muciniphila in a complex microbiota, we 149 cultured fecal samples supplemented with A. muciniphila in two separate 150 gut-simulators, and exposed them to a constant flow of PBG (40 mg/mL) for 42 h. No 151 substantial difference in the abundance of A. muciniphila was observed following PBG 152 exposure ( Fig.4b ).
153
To address whether PBG could alter host physiology and thus facilitate A. 154 muciniphila colonization, we treated mice with an antibiotic cocktail for one month to 155 deplete gut microbiota. The microbiota-depleted mice were further treated daily with 156 PBG or PBS, along with the antibiotic cocktail to prevent recurrence of microbiota for another month. The mice were lavaged with A. muciniphila (2 × 10 8 cfu / 0.2ml) 158 continuously for 3 days and its abundance in the fecal samples was determined 24 h 159 after each lavage. The amount of A. muciniphila was statically different at day 3 in 160 feces between PBG-treated mice and control mice (Fig.4c ).This observation suggested 161 that PBG created an intestinal microenvironment favorable for A. muciniphila 162 colonization.
163
A. muciniphila degrades intestinal mucins, the highly glycosylated proteins of the 164 epithelial mucus layer, as its preferred source of carbon and nitrogen (21). Alterations 165 of the mucus could be caused either by modification of gene expression that encode for 166 the mucins (MUC genes) and/or of genes encoding for glycosyltransferases (GT genes) 167 (22-24). We did not observe significant differences in gene expression of mucin 2 168 protein (encode by MUC2 gene) and its related glycosyltransferases (C1galt1 and 169 C2gnt genes) in colon tissues from PBG-treated mice and control mice ( Fig.4d ), 170 suggesting that A. muciniphila is not simply responding to increased host mucin 171 production.
172

Fecal microbiota transplantation from PBG-treated mice reduces obesity 173
It is well-known that alteration of gut microbiota by the transfer of foreign fecal 174 materials could modulate obesity (25). We daily transferred fecal microbiota from the 
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Correspondingly, the obesity-related metabolic inflammation, as indicated by elevated 182 serum levels of proinflammatory cytokines such as IL-6, IL-1β and TNF-α in the 183 recipient mice was also diminished after the first three fecal microbiota transplantation 184 above ( Fig. 5d-f ). These results suggest that the anti-obesity effects of PBG in 185 HFD-fed mice might be due to modulation of the gut microbiota.
186
PBG directly upregulates a set of gene expression involved in host metabolism
187
To find out whether PBG has a direct impact on host metabolism, we performed to lipid metabolism were mostly enriched, including fat digestion and absorption, 203 glycosphinglipid biosynthesis, linoleic aicd metabolism and bile secretion ( Fig. 6c ).
204
These included a set of DEGs such as B3gnt5, Abcg8, Gyk, St8sia5, Pla2g2f, Aqp8, 205 Abcg5, Pla2g4f, Fut9, Adh1, and Cyp2c68 which were highly upregulated in colon 206 tissues from PBG-treated mice (Table S1 ). These findings indicated that PBG could 207 promote host lipid metabolism, regardless of gut microbiota. (Table S1 ). The most pronounced one is CTSE gene, which encodes 218 cathepsin E, an aspartic endopeptidase involved in antigen processing via the MHC 219 class II pathway (28). Besides, several sets of genes related to elements of Toll-like or 220 NOD-like signaling pathway and the complement system are upregulated (Table S1 ).
221
These data suggest that PBG can activate innate and adaptive immunity in the intestine.
222
Paradoxically, PBG suppresses systemic metabolic inflammation in HFD-fed obese 223 animal models (Fig.2) . Further evidences showed that this was due to PBG's ability to Table S2 . 
276
Body fat and lean mass were determined in live conscious mice with adlibitum access 277 to chow as previously described (38).
278
H&E Staining
279
Liver was fixed in 10% buffered formalin at room temperature before embedding 280 in paraffin. Histological assessment of H&E sections was performed in a blinded 281 fashion by a pathologist using a previously described scoring system (39). Table S3 (40, 41).
294
Gut microbiota analysis 295 Stool samples were snap-frozen in liquid nitrogen before storage at -80°C. Total In vitro gut simulator 308 A three compartment dynamic in vitro human intestinal tract model (SHIME) was 309 used to study the effects of PBG on a stabilized gut microbial community in a 310 controlled in vitro setting (43).
311
A. muciniphila colonization 312
C57Bl/6J female mice ( 4 weeks old) were fed with HFD and treated with an 313 antibiotic cocktail for 4 weeks as described (44). The microbiota-depleted mice were 314 daily supplementated with or without PBG (400 mg/kg) for another month in the 315 presence of antibiotics. Mice were lavaged with A. muciniphila (1.5 × 10 8 cfu) 316 continuously for 3 days as previously described (32). Fecal samples were collected 24 317 h after each lavage and Akkermansia muciniphila in the feces was quantified by qPCR 318 using the universal 16S rRNA gene primers (shown in Table S3 ). Northwest A&F University (2452017026).
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